Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution

Figure 2

Assessment and optimization of MTB/MTB-L detection assay. 31 TB, non-lung-cancer samples and 39 non-TB, non-lung-cancer samples were used as the test set. As the cause of TB, MTB-L was expected to be present in the TB, non-lung-cancer but absent in the non-TB, non-lung-cancer samples. (a) Detection of MTB-L by the IK method alone. (b) Detection of MTB/MTB-L by the IK method and the mpb64 marker.

(a)

(b)